Cure My Disease

Don't miss your cure!

 Log in / Sign up

High-Tech light game could sharpen MS Patients' minds and steps

NCT ID NCT06874764

Symptom relief Sponsor: Ege University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether training with a wireless lighting reaction system can improve cognitive functions and walking in people with multiple sclerosis (MS). Forty participants aged 18-55 with mild disability will perform agility and cognitive exercises using the device. The goal is to see if this technology-supported training can boost thinking speed, balance, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wireless Lighting Reaction System Training (agility and cognitive exercises)
What this could lead to
If it works, this could point toward a simple, technology-based exercise program to help people with MS think more clearly and walk better.
What could go wrong
This is a small, early-stage study with only 40 people. The training may not lead to meaningful improvements, and results may not apply to all people with MS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being between the ages of 18-55 * Having a definite MS diagnosis according to the 2017 McDonald criteria. * EDSS score of 4 or below * Being able to communicate (speaking and understanding Turkish, no speech disorders) Exclusion Criteria: * Regular exercise in the last 6 months * Having an MS attack in the last month * Having an MS attack during the study period * Presence of additional accompanying neurological diseases * Use of dalfampridine * Use of antipsychotic and psychostimulant drugs * Drug and alcohol addiction * Pregnancy, breastfeeding * No chronic systemic disease preventing exercise * Patients who cannot reach the targeted exercise level

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ege University Sport Medicine Clinic

    Izmir, Bornova, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.